Skip to main content
. 2019 Jul 4;9:9715. doi: 10.1038/s41598-019-46064-4

Figure 7.

Figure 7

HSPB8 expression is downregulated in metastatic prostate cancer. (a) Comparison of AR, HOXB13, and HSPB8 gene expression in bone metastatic CRPCs (GSE101607) **p < 0.005, ****p < 0.0005. (b) GSE6752 which comprised 10 primary and 21 androgen ablation resistant metastatic samples. ****p < 0.0005. (c) GSE67980 (human primary and metastatic cases) ***p < 0.005; *p < 0.05. ns = not significant. (d) Moffitt TCC primaries. ****p < 0.0005; *** p < 0.005. (e) Moffitt TCC metastasis. ****p < 0.0005. (f) Moffitt TCC Data Set. ****p < 0.0005. (g) AR/HOXB13 co-expression is observed in 94 (63%) of metastatic PC cases (SU2C/PCF cohort, Cell 2015). HSPB8 expression inversely correlates with AR and HOXB13 expression. Pearson co-relation co-efficient and Spearman rank co-efficient are shown below each panel.